SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum
Authors:
- A. BoukhrisABA. Boukhris
- D. MalteteDMD. Maltete
- L. Guyant-MaréchalLGL. Guyant-Maréchal
- J. TruchettoJTJ. Truchetto
- E. MundwillerEME. Mundwiller
- S. HaneinSHS. Hanein
- P. JonveauxPJP. Jonveaux
- F. RoelensFRF. Roelens
- J. LoureiroJLJ. Loureiro
- E. GodetEGE. Godet
- S. ForlaniSFS. Forlani
- 6 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 73 (14) , 1111-1119
Abstract
Objective: Hereditary spastic paraplegias (HSPs) are very heterogeneous inherited neurodegenerative disorders. Our group recently identified ZFYVE26 as the gene responsible for one of the clinical and genetic entities, SPG15. Our aim was to describe its clinical and mutational spectra. Methods: We analyzed all exons of SPG15/ZFYVE26 gene by direct sequencing in a series of 60 non-SPG11 HSP subjects with associated mental or MRI abnormalities, including 30 isolated cases. The clinical data were collected through the SPATAX network. Results: We identified 13 novel truncating mutations in ZFYVE26, 12 of which segregated at the homozygous or compound heterozygous states in 8 new SPG15 families while 1 was found at the heterozygous state in a single family. Two of 3 splice site mutations were validated on mRNA of 2 patients. The SPG15 phenotype in 11 affected individuals was characterized by early onset HSP, severe progression of the disease, and mental impairment dominated by cognitive decline. Thin corpus callosum and white matter hyperintensities were MRI hallmarks of the disease in this series. Conclusions: The mutations are truncating, private, and distributed along the entire coding sequence of ZFYVE26, which complicates the analysis of this gene in clinical practice. In our series of patients with hereditary spastic paraplegia–thin corpus callosum, the largest analyzed so far, SPG15 was the second most frequent form (11.5%) after SPG11. Both forms share similar clinical and imaging presentations with very few distinctions, which are, however, insufficient to infer the molecular diagnosis when faced with a single patient.Keywords
This publication has 25 references indexed in Scilit:
- Spastic paraplegia with thinning of the corpus callosum and white matter abnormalities: Further mutations and relative frequency in ZFYVE26/SPG15 in the Italian populationJournal of the Neurological Sciences, 2009
- Novel mutations of the SPG11 gene in hereditary spastic paraplegia with thin corpus callosumJournal of the Neurological Sciences, 2008
- A Missense Mutation in SLC33A1, which Encodes the Acetyl-CoA Transporter, Causes Autosomal-Dominant Spastic Paraplegia (SPG42)The American Journal of Human Genetics, 2008
- Identification of a heterozygous genomic deletion in the spatacsin gene in SPG11 patients using high-resolution comparative genomic hybridizationneurogenetics, 2008
- Complicated autosomal recessive hereditary spastic paraplegiaNeurology, 2008
- Identification of the SPG15 Gene, Encoding Spastizin, as a Frequent Cause of Complicated Autosomal-Recessive Spastic Paraplegia, Including Kjellin SyndromeThe American Journal of Human Genetics, 2008
- Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron DegenerationThe American Journal of Human Genetics, 2008
- Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degenerationBrain, 2007
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001
- ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFNature Genetics, 2000